Functional Medicine
Testosterone Therapy and Breast Cancer Incidence Study
BHRT Study Shows 35.5% Lower Incidence of Breast Cancer in Women Treated with Subcutaneous Testosterone BioTE founder Gary Donovitz, MD, FACOG, and Mandy Cotten, DNP,
BHRT Study Shows 35.5% Lower Incidence of Breast Cancer in Women Treated with Subcutaneous Testosterone BioTE founder Gary Donovitz, MD, FACOG, and Mandy Cotten, DNP,
315 W. South Boulder Road, Suite 208
Louisville, CO 80027
FOLLOW US
Receive the Box Breathing Method to help you calmly get through your busy days.